← All tickers

Is EVH Worth Buying in 2026?

Evolent Health, Inc Class A Common Stock

STOCK SERVICES-MANAGEMENT SERVICES Updated 2026-06-14

Here’s whether Evolent Health, Inc Class A Common Stock (EVH) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.

🟢
Bullish

Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+12.54% over 10 days); RSI 65 — healthy momentum range; 3-month momentum positive (+58.9%). Concerns: weak 1-year return of -43.2%. Currently 60.2% off its 52-week high. Score: +5/7.

Ready to act on this? 📈 Trade on Webull

EVH is in a confirmed uptrend, trading above both its 50-day ($3.62) and 200-day ($4.76) moving averages. An RSI of 64.6 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of -43.2% compares to +22.9% for SPY (trailed the market by 66.1%). The current 60.2% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $5,680 today
vs. S&P 500 (SPY) — same period trailed market by 66.1%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

✓Above 200-day MA ($4.76)
✓Above 50-day MA ($3.62)
✓RSI(14) neutral zone (30–70) — currently 64.6
✗Positive return (-43.2%)
!Within 10% of period high (−60.2%)
Period Range $4.80
$2.10 $12.07
RSI (14) 64.6
0 · OversoldOverbought · 100

Key Metrics

Price$4.80
Period Return-43.2%
Period High$12.07
Period Low$2.10
Drawdown−60.2%
MA-50$3.62
MA-200$4.76
RSI (14)64.6
Avg Volume (30d)2.7M
vs. SPYtrailed by 66.1%
Return Rank#1035 of 1246

Trade EVH

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers